Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:02CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026279SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.04.CV Sciences, Inc. - 8-K, Current Report-
CV SCIENCES Aktie jetzt für 0€ handeln
26.03.CV Sciences outlines non-cannabinoid product launches and margin gains as company targets cash flow breakeven through 20261
26.03.CV Sciences, Inc. - 10-K, Annual Report2
26.03.CV Sciences Non-GAAP EPS of $0.00, revenue of $13.79M2
26.03.CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results500SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
24.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026351SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.03.CV Sciences, Inc.: CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth445SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven,...
► Artikel lesen
26.02.CV Sciences, Inc.: CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness373With 20g of clean protein, 5g of creatine, and LactoSpore probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition...
► Artikel lesen
23.12.25CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD675SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
14.11.25CV Sciences outlines new non-cannabinoid product launches in 2026 while adapting to regulatory changes4
13.11.25CV Sciences, Inc. Reports Third Quarter 2025 Financial Results350SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
11.11.25CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025437SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing...
► Artikel lesen
27.08.25CV Sciences, Inc.: CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus596Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCESS...
► Artikel lesen
13.08.25CV Sciences, Inc. Reports Second Quarter 2025 Financial Results394SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
08.08.25CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025668SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
► Artikel lesen
24.06.25CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3491SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
14.05.25CV Sciences, Inc. Reports First Quarter 2025 Financial Results459SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1